WASHINGTON (Reuters)—The U.S. Food and Drug Administration on Friday approved a cheaper, biosimilar version of AbbVie’s top-selling arthritis drug, adalimumab (Humira). The drug, adalimumab-atto (Amjevita), is made by biotechnology company Amgen Inc. and was approved to treat rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and other conditions. Amjevita is the fourth biosimilar to be approved…
How to Thrive—Not Just Survive—as a New Manager, Part 1
The transition from employee to manager in a rheumatology practice can be daunting. But according to experts, setting clear roles and responsibilities and cultivating professional relationships with your employees ultimately help make you and the practice successful…
Celltrion Accelerates U.S. Launch of Infliximab-dyyb, a Remicade Biosimilar
After winning the initial patent infringement lawsuit filed by Janssen, Celltrion Inc. is now shipping Inflectra (infliximab-dyyb), a biosimilar of Remicade (infliximab), to the U.S…
Is Arthroscopic Meniscal Surgery Effective?
A recent review examined the effectiveness of arthroscopic mensical surgery in treating meniscal injuries. Researchers determined that little evidence exists to support the use of arthroscopic meniscal surgery and more studies that directly compare it with nonoperative treatments are needed…
Novel Astrocytic Autoantibody Associated with Relapsing Meningoencephalomyelitis
NEW YORK (Reuters Health)—An autoantibody to glial fibrillary acidic protein (GFAP) is associated with relapsing autoimmune meningoencephalomyelitis that is responsive to immunotherapy, researchers report. “Autoimmune GFAP meningoencephalomyelitis is the second autoimmune neurological disease in which the target of the immune attack is recognized to be the astrocyte type of brain cell,” Dr. Vanda A. Lennon…
U.S. Justice Department to Push Prosecutors on Opioids
WASHINGTON (Reuters)—The U.S. Justice Department will enlist federal prosecutors to help fight the nation’s opioid crisis by sharing information on overprescribing doctors and coordinating with public health officials to address addiction, USA Today reported on Friday. “You can’t just have an enforcement strategy alone,” Attorney General Loretta Lynch told the newspaper in an interview. She…
Common Sense Tips for Rheumatologists on Social Media
Using social media goes beyond self-promotion, says David Deutsch. “If you can give prospective patients something that changes their lives, they will care about you.” A few thoughts on social media and rheumatology practices…
Abaloparatide Promising for Osteoporosis; NICE Draft Guidelines Include Secukinumab for Ankylosing Spondylitis
In a clinical trial, subcutaneous abaloparatide has proved effective in treating postmenopausal women with osteoporosis. Also in the U.K., draft guidelines for treating ankylosing spondylitis will recommend the use of secukinumab…
Medicare Program Focuses on Rural Patients
For arthritis patients who live in farming communities, just getting to rheumatologist Lynne Peterson, MD’s, office in Bismarck, N.D., can take a lot of time and energy. “Because of the shortage of rheumatologists, patients living in rural areas tend to receive inadequate rheumatologic evaluation and care,” says Dr. Peterson, whose clinic is located at Sanford…
How to Get Your EHR Up … & Keep It Running
Implementing a new electronic health record (EHR) system is no easy task—and one that a physician shouldn’t tackle alone. From the onset, you need to get buy-in from your practice’s colleagues. To do this, designate a physician champion to take charge of the effort. “This is a challenging position, because it’s difficult to convince people…
- « Previous Page
- 1
- …
- 439
- 440
- 441
- 442
- 443
- …
- 778
- Next Page »